Bayer falling 30%

Bayer said it is halting a trial for asundexian, an experimental cardiovascular drug. Bayer’s Frankfurt-listed shares (XE:BAYN) fell about 30%. Bayer is a hundred and fifty years old German giant pharma company, tremendously stable, conservatively managed and reliable. Losing a third of its worth in a day or two is most amazing. It means that one third of its worth was the hope for the success of an experfimental drug. I have blind faith in German quality. Just bought German car.